Pelthos Therapeutics Stock Price, News & Analysis

PTHS NYSE

Company Description

Welcome to the overview page for Pelthos Therapeutics (PTHS), where you can find comprehensive stock information and company updates.

Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.

Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.

Stock Performance

Chart

$18.45

+0.71%

+0.13

Last updated: July 13, 2025 at 19:55

- %

Performance 1 year

$10.7M

Market Cap

659.6K

Shares outstanding

Latest News

View All

2 days ago

60.78%

Pelthos Therapeutics Launches ZELSUVMI™ (berdazimer) Topical Gel 10.3%, the First and Only FDA-Approved At-Home Treatment for Molluscum Contagiosum

fda approval

11 days ago

0.00%

Pelthos Therapeutics Completes Merger with Channel Therapeutics and Closes $50.1 Million Private Placement

private placement acquisition

SEC Filings

View All

No SEC filings available for Pelthos Therapeutics.

Financial Highlights

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Frequently Asked Questions

What is the current stock price of Pelthos Therapeutics (PTHS)?

The current stock price of Pelthos Therapeutics (PTHS) is $18.32 as of July 11, 2025.

What is the market cap of Pelthos Therapeutics (PTHS)?

The market cap of Pelthos Therapeutics (PTHS) is approximately 10.7M.